Recurrent Breast Cancer Completed Phase 3 Trials for Trastuzumab (DB00072)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

DBCOND0028640 (Recurrent Breast Cancer)Completed3 IdentifierTitlePurposeDrugs
NCT00003440Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or MetastaticTreatment